LadRx (STU:CX5) Short Interest


STU:CX5 LadRx Corp STU:CX5
40 GF Score
Price €0.06
View Full Analysis

What is LadRx Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:CX5 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, LadRx's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LadRx Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LadRx's Short Interest distribution charts can be found below:

* The bar in red indicates where LadRx's Short Interest falls into.


STU:CX5
40GF Score
LadRx Corp STU:CX5
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LadRx Business Description

Address 11726 San Vicente Boulevard, Suite 650, Los Angeles, CA, USA, 90049
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
40GF Score

Get the complete analysis for STU:CX5

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price